| |
| |
|
| Insider
Information: |
Clancy Paul J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
138,295 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,757,220 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
138,295 |
|
|
| Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-08 |
4 |
D |
$164.44 |
$147,832 |
D/D |
(899) |
25,478 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-09 |
4 |
D |
$164.44 |
$284,646 |
D/D |
(1,731) |
28,439 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-23 |
4 |
D |
$164.40 |
$332,252 |
D/D |
(2,021) |
30,699 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-08 |
4 |
D |
$315.54 |
$330,370 |
D/D |
(1,047) |
9,231 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-09 |
4 |
D |
$315.54 |
$697,974 |
D/D |
(2,212) |
11,710 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-12 |
4 |
D |
$323.04 |
$427,705 |
D/D |
(1,324) |
13,193 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2014-02-23 |
4 |
D |
$347.11 |
$700,468 |
D/D |
(2,018) |
15,455 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-08 |
4 |
D |
$402.00 |
$459,486 |
D/D |
(1,143) |
17,503 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-09 |
4 |
D |
$396.88 |
$877,105 |
D/D |
(2,210) |
19,984 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2015-02-12 |
4 |
D |
$392.11 |
$794,415 |
D/D |
(2,026) |
22,257 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2016-02-08 |
4 |
D |
$250.77 |
$262,556 |
D/D |
(1,047) |
24,404 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2016-02-12 |
4 |
D |
$247.22 |
$420,027 |
D/D |
(1,699) |
26,564 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2016-02-23 |
4 |
D |
$258.99 |
$70,704 |
D/D |
(273) |
26,870 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2017-02-28 |
4 |
D |
$274.76 |
$853,135 |
D/D |
(3,054) |
30,596 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-07 |
4 |
D |
$119.57 |
$715,148 |
D/D |
(5,981) |
87,328 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-02-28 |
4 |
D |
$132.93 |
$143,431 |
D/D |
(1,079) |
86,249 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
• – – |
2019-07-11 |
4 |
D |
$124.20 |
$649,566 |
D/D |
(5,230) |
90,447 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
CFOOfficer |
• – – |
2007-08-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,395 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,521 |
47,618 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-03-05 |
4 |
OE |
$58.99 |
$1,695,963 |
D/D |
28,750 |
73,085 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2011-04-28 |
4 |
OE |
$37.45 |
$608,119 |
D/D |
14,766 |
51,958 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• – – |
2012-02-01 |
4 |
OE |
$43.50 |
$1,133,088 |
D/D |
21,400 |
42,568 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,765 |
26,377 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,692 |
30,170 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP and CFO |
• • – |
2013-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,281 |
32,720 |
0 |
- |
|
119 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
